Aligos Belgium
Gaston Geenslaan 1/(Gebouw 3)
3001 Leuven
BE
Aligos Belgium
Foundation date
10/09/2018
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
ALIGOS BELGIUM is the European branch of Aligos Therapeutics. It's a biotechnology company developing novel therapeutic agents to treat significant liver diseases.
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
3011 '23
The GxP Academy: Aseptische Training en werken in LAF/Biosafety Cabinet
Event by: Advipro
Latest news
More news-
argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia
21 hours ago
Read more
-
Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion
Wednesday November 22nd 2023
Read more
-
argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis
Thursday November 16th 2023
Read more
Jobs
More jobs-
-
-
27/11/23
Antwerp, Brussels, East Flanders, Hainaut, Liège, Limburg, Luxembourg, Namur, Flemish Brabant, Walloon Brabant, West Flanders, Remote
Project Manager Life Science & IVD
Permanent
Thema Group Belgium
More info?
Contact us
Ellen Telleir
Communication Coordinator